» home    
 
 
01/01/14
Nanogea Signs Research Collaboration Agreement with CHA Hospital.
02/01/13
Nanogea Receives Research Grant from Postech Industrial Collaboration Research Institute.
 
 
Nanogea is a nano-bioscience company focused on commercializing the industry’s most sensitive single molecular detection platform based on its innovative NanoConeTM chemistry and NanoCone Enabled Atomic Force (NE-AFMTM) technology.

Nanogea’s technology represents a dramatic advancement in the field of molecular diagnostics. Nanogea’s NE-AFMTM offers an unprecedented 106 X improvement in sensitivity over other leading diagnostic technologies, thereby enabling significantly early and accurate detection of diseases. Its superior sensitivity also eliminates the need for the complex and costly sample preparation as well as target amplification steps – which are known to cause false positives.

Nanogea is currently working with the faculty members of UCLA, University of Texas, USC, and Catholic University of Korea to bring to people early and accurate diagnosis of cancer and infectious disease as well as other medical applications.
 
© 2009 Nanogea, Inc. All rights reserved. Home | People | Technolgy | News | Contact
Web Design by fullestop